Status of hormones and painkillers in wastewater effluents across several European states-considerations for the EU watch list concerning estradiols and diclofenac

Basit Öğe Kaydı
dc.authorid0000-0002-7409-0235
dc.authorid0000-0003-4340-6118
dc.authorid0000-0002-0569-0982
dc.authorid0000-0003-4872-3411
dc.authorid0000-0003-4872-3411
dc.authorid0000-0002-8615-8989
dc.authorid0000-0001-9981-0983
dc.authorscopusid7005968780
dc.authorscopusid6603109791
dc.authorscopusid7003271130
dc.authorscopusid9242899200
dc.authorscopusid36454063600
dc.authorscopusid7006635643
dc.authorscopusid6602551155
dc.authorwosidCARBALLA, MARTA/P-7454-2015
dc.authorwosidMartinez-Lopez, Emma/H-1685-2015
dc.authorwosidMartínez-López, Emma/AAB-3097-2019
dc.authorwosidTsagarakis, Konstantinos P./N-1403-2017
dc.authorwosidSchroeder, Peter/AAP-7988-2020
dc.authorwosidPapa, Matteo/AAH-3731-2020
dc.authorwosidPapa, Matteo/E-5731-2012
dc.contributor.authorSchröder, Peter
dc.contributor.authorHelmreich, Brigitte
dc.contributor.authorSkrbic, Bilijana
dc.contributor.authorCarballa, Marta
dc.contributor.authorPapa, Matteo
dc.contributor.authorPastore, Carlo
dc.contributor.authorMascolo, Giuseppe
dc.contributor.authorPagano Meriç, Süreyya
dc.date.accessioned2022-05-11T14:17:19Z
dc.date.available2022-05-11T14:17:19Z
dc.date.issued2016
dc.departmentFakülteler, Çorlu Mühendislik Fakültesi, Çevre Mühendisliği Bölümü
dc.description.abstractPresent technologies for wastewater treatment do not sufficiently address the increasing pollution situation of receiving water bodies, especially with the growing use of personal care products and pharmaceuticals (PPCP) in the private household and health sector. The relevance of addressing this problem of organic pollutants was taken into account by the Directive 2013/39/EU that introduced (i) the quality evaluation of aquatic compartments, (ii) the polluter pays principle, (iii) the need for innovative and affordable wastewater treatment technologies, and (iv) the identification of pollution causes including a list of principal compounds to be monitored. In addition, a watch list of 10 other substances was recently defined by Decision 2015/495 on March 20, 2015. This list contains, among several recalcitrant chemicals, the painkiller diclofenac and the hormones 17 beta-estradiol and 17 alpha-ethinylestradiol. Although some modern approaches for their removal exist, such as advanced oxidation processes (AOPs), retrofitting most wastewater treatment plants with AOPs will not be acceptable as consistent investment at reasonable operational cost. Additionally, by-product and transformation product formation has to be considered. The same is true for membrane-based technologies (nanofiltration, reversed osmosis) despite of the incredible progress that has been made during recent years, because these systems lead to higher operation costs (mainly due to higher energy consumption) so that the majority of communities will not easily accept them. Advanced technologies in wastewater treatment like membrane bioreactors (MBR) that integrate biological degradation of organic matter with membrane filtration have proven a more complete elimination of emerging pollutants in a rather cost- and labor-intensive technology. Still, most of the presently applied methods are incapable of removing critical compounds completely. In this opinion paper, the state of the art of European WWTPs is reflected, and capacities of single methods are described. Furthermore, the need for analytical standards, risk assessment, and economic planning is stressed. The survey results in the conclusion that combinations of different conventional and advanced technologies including biological and plant-based strategies seem to be most promising to solve the burning problem of polluting our environment with hazardous emerging xenobiotics.
dc.description.sponsorshipCOSTEuropean Cooperation in Science and Technology (COST)
dc.description.sponsorshipThis opinion paper has been compiled by members of COST Action ESSEM1202 (www.water2020.eu) on the basis of fruitful discussions in a task force focusing on emerging contaminants. The authors acknowledge the financial support by COST (www.cost.eu) for their meetings.
dc.identifier.doi10.1007/s11356-016-6503-x
dc.identifier.endpage12866
dc.identifier.issn0944-1344
dc.identifier.issn1614-7499
dc.identifier.issue13en_US
dc.identifier.pmid27023823
dc.identifier.scopus2-s2.0-84962273575
dc.identifier.scopusqualityQ1
dc.identifier.startpage12835
dc.identifier.urihttps://doi.org/10.1007/s11356-016-6503-x
dc.identifier.urihttps://hdl.handle.net/20.500.11776/6314
dc.identifier.volume23
dc.identifier.wosWOS:000378817300026
dc.identifier.wosqualityQ2
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.institutionauthorPagano Meriç, Süreyya
dc.language.isoen
dc.publisherSpringer Heidelberg
dc.relation.ispartofEnvironmental Science and Pollution Research
dc.relation.publicationcategoryDiğeren_US
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectDiclofenac
dc.subjectEthinylestradiol
dc.subjectEmerging pollutants
dc.subjectEffluent quality
dc.subjectEU watch list
dc.subjectPollutant removal
dc.subjectAdvanced technologies
dc.subjectPersonal Care Products
dc.subjectEndocrine Disrupting Compounds
dc.subjectAdvanced Oxidation Processes
dc.subjectSewage-Treatment Plants
dc.subjectLinear Ion-Trap
dc.subjectEnvironmental Risk-Assessment
dc.subjectAccurate Mass Measurements
dc.subjectPowdered Activated Carbon
dc.subjectNeutral Photo-Fenton
dc.subjectPharmaceutical Residues
dc.titleStatus of hormones and painkillers in wastewater effluents across several European states-considerations for the EU watch list concerning estradiols and diclofenac
dc.typeReview Article

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
6314.pdf
Boyut:
1020.81 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
İndir

Koleksiyon

WoS İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu
Scopus İndeksli Yayınlar Koleksiyonu
Çorlu Mühendislik Fakültesi Koleksiyonu